{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:32Z","timestamp":1707524072868},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,14]]},"DOI":"10.7759\/cureus.8611","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T09:35:42Z","timestamp":1592127342000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics and Outcomes of Primary Breast Lymphoma: The Cleveland Clinic Experience"],"prefix":"10.7759","author":[{"given":"Tariq","family":"Kewan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahrettin","family":"Covut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdo","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Daw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.09.004","article-title":"Primary breast lymphoma: analysis of 55 cases of the Spanish lymphoma oncology group","volume":"17","author":"Franco P\u00e9rez F","year":"2017","unstructured":"Franco P\u00e9rez F, Lavernia J, Aguiar-Bujanda D, et al.. Primary breast lymphoma: analysis of 55 cases of the Spanish lymphoma oncology group. Clin Lymphoma Myeloma Leuk. 2017, 17:186-191. 10.1016\/j.clml.2016.09.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw294","article-title":"Primary breast lymphoma in the United States: 1975-2013","volume":"109","author":"Thomas A","year":"2017","unstructured":"Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary breast lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017, 109:djw294. 10.1093\/jnci\/djw294","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23285","article-title":"Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014","volume":"9","author":"Jia Y","year":"2017","unstructured":"Jia Y, Sun C, Liu Z, Wang W, Zhou X. Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014. Oncotarget. 2017, 9:3956-3967. 10.18632\/oncotarget.23285","journal-title":"Oncotarget"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197206)29:6<1705::aid-cncr2820290640>3.0.co;2-i","article-title":"Primary lymphoma of the breast","volume":"29","author":"Wiseman C","year":"1972","unstructured":"Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972, 29:1705\u20101712. 10.1002\/1097-0142(197206)29:6&lt;1705::aid-cncr2820290640&gt;3.0.co;2-i","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901215)66:12<2602::aid-cncr2820661224>3.0.co;2-u","article-title":"Primary breast lymphoma: an immunohistologic study of 20 new cases","volume":"66","author":"Hugh JC","year":"1990","unstructured":"Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma: an immunohistologic study of 20 new cases. Cancer. 1990, 66:2602\u20102611. 10.1002\/1097-0142(19901215)66:12&lt;2602::aid-cncr2820661224&gt;3.0.co;2-u","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Cheah CY","year":"2014","unstructured":"Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014, 40:900-908. 10.1016\/j.ctrv.2014.05.010","journal-title":"Cancer Treat Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8803","article-title":"Primary extra-nodal diffuse large B-cell lymphoma: a prognostic analysis of 141 patients","volume":"16","author":"Shen H","year":"2018","unstructured":"Shen H, Wei Z, Zhou D, et al.. Primary extra-nodal diffuse large B-cell lymphoma: a prognostic analysis of 141 patients. Oncol Lett. 2018, 16:1602-1614. 10.3892\/ol.2018.8803","journal-title":"Oncol Lett"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180097","article-title":"Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review","volume":"39","author":"Raj SD","year":"2019","unstructured":"Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MDC, Dialani VM. Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review. Radiographics. 2019, 39:610-625. 10.1148\/rg.2019180097","journal-title":"Radiographics"},{"key":"ref9","article-title":"Prognostic analysis of primary breast diffuse large B cell lymphoma (Article in Chinese)","volume":"41","author":"Zhu YH","year":"2019","unstructured":"Zhu YH, Meng WJ, He LH, Jia YS, Tong ZS. Prognostic analysis of primary breast diffuse large B cell lymphoma (Article in Chinese). Zhonghua Zhong Liu Za Zhi. 2019, 41:235\u2010240.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5483","article-title":"Primary breast lymphoma: a single center study","volume":"13","author":"Zhang N","year":"2017","unstructured":"Zhang N, Cao C, Zhu Y, et al.. Primary breast lymphoma: a single center study. Oncol Lett. 2017, 13:1014-1018. 10.3892\/ol.2016.5483","journal-title":"Oncol Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.12.016","article-title":"Emerging treatment strategies for primary breast extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"19","author":"Ludmir EB","year":"2019","unstructured":"Ludmir EB, Milgrom SA, Pinnix CC, et al.. Emerging treatment strategies for primary breast extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clin Lymphoma Myeloma Leuk. 2019, 19:244-250. 10.1016\/j.clml.2018.12.016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e318195286d","article-title":"Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases","volume":"17","author":"Gualco G","year":"2009","unstructured":"Gualco G, Chioato L, Harrington WJ Jr, Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol. 2009, 17:301-306. 10.1097\/PAI.0b013e318195286d","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21353","article-title":"Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors","volume":"84","author":"Validire P","year":"2009","unstructured":"Validire P, Capovilla M, Asselain B, et al.. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol. 2009, 84:133-139. 10.1002\/ajh.21353","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-321","article-title":"Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study","volume":"10","author":"Yhim HY","year":"2010","unstructured":"Yhim HY, Kang HJ, Choi YH, et al.. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. BMC Cancer. 2010, 10:321. 10.1186\/1471-2407-10-321","journal-title":"BMC Cancer"},{"key":"ref15","article-title":"Clinical efficacy of EPOCH+\/-R followed by DICE+\/-R regimen for primary breast diffuse large B-cell lymphoma (Article in Chinese)","volume":"25","author":"Dong LH","year":"2017","unstructured":"Dong LH, Chen JL, Gao X, Li GP, Li YF, Song YP, Wei XD. Clinical efficacy of EPOCH+\/-R followed by DICE+\/-R regimen for primary breast diffuse large B-cell lymphoma (Article in Chinese). Zhongguo Shi Yan Xue Ye Xue Za. 2017, 25:766-771.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13828","article-title":"Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure","volume":"109","author":"Hu S","year":"2018","unstructured":"Hu S, Song Y, Sun X, et al.. Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure. Cancer Sci. 2018, 109:3943-3952. 10.1111\/cas.13828","journal-title":"Cancer Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1460825","article-title":"Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure","volume":"59","author":"Ludmir EB","year":"2018","unstructured":"Ludmir EB, Milgrom SA, Pinnix CC, et al.. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure. Leuk Lymphoma. 2018, 59:2896-2903. 10.1080\/10428194.2018.1460825","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1457","article-title":"Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis","volume":"7","author":"Liu PP","year":"2018","unstructured":"Liu PP, Wang KF, Jin JT, et al.. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Med. 2018, 7:1845-1851. 10.1002\/cam4.1457","journal-title":"Cancer Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm471","article-title":"Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group","volume":"19","author":"Ryan G","year":"2008","unstructured":"Ryan G, Martinelli G, Kuper-Hommel M, et al.. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008, 19:233-241. 10.1093\/annonc\/mdm471","journal-title":"Ann Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"36","author":"Harris NL","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology. 2000, 36:69\u201086. 10.1046\/j.1365-2559.2000.00895.x","journal-title":"Histopathology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12753","article-title":"A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era","volume":"165","author":"Hosein PJ","year":"2014","unstructured":"Hosein PJ, Maragulia JC, Salzberg MP, et al.. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014, 165:358-363. 10.1111\/bjh.12753","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000254418.90192.59","article-title":"Primary breast lymphoma: the role of mastectomy and the importance of lymph node status","volume":"245","author":"Jennings WC","year":"2007","unstructured":"Jennings WC, Baker RS, Murray SS, et al.. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg. 2007, 245:784-789. 10.1097\/01.sla.0000254418.90192.59","journal-title":"Ann Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.004","article-title":"Analysis of 31 cases of primary breast lymphoma: the effect of nodal involvement and microvascular density","volume":"11","author":"Zhao S","year":"2011","unstructured":"Zhao S, Zhang QY, Ma WJ, et al.. Analysis of 31 cases of primary breast lymphoma: the effect of nodal involvement and microvascular density. Clin Lymphoma Myeloma Leuk. 2011, 11:33-37. 10.3816\/CLML.2011.n.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000088333","article-title":"Primary breast lymphoma: results of a controlled clinical trial","volume":"69","author":"Avil\u00e9s A","year":"2005","unstructured":"Avil\u00e9s A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology. 2005, 69:256-260. 10.1159\/000088333","journal-title":"Oncology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt192","article-title":"Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options","volume":"24","author":"Aviv A","year":"2013","unstructured":"Aviv A, Tadmor T, Polliack A. Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol. 2013, 24:2236-2244. 10.1093\/annonc\/mdt192","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/32786-clinical-characteristics-and-outcomes-of-primary-breast-lymphoma-the-cleveland-clinic-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:31Z","timestamp":1707506611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/32786-clinical-characteristics-and-outcomes-of-primary-breast-lymphoma-the-cleveland-clinic-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,14]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.8611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,14]]}}}